NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its first quarter revenues were up two percent year over year, driven by increased sales for its Oncotype DX tests.

The Redwood City, California-based molecular diagnostics firm brought in total revenues of $68.2 million for the three months ended March 31, up from $67 million in the first quarter of 2014 but below the consensus Wall Street estimate of $69.9 million. All of its revenue in the quarter came from product sales.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.